Cargando…

Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis

Lockdown due to the Coronavirus disease 2019 (COVID 19) pandemic may cause weight gain and enhance the risk of type 2 diabetes mellitus (T2DM). We aimed to determine this risk in apparently non-diabetic individuals. MATERIAL METHODS: Baseline demographic and clinical data from 100 apparently non-dia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghosal, Samit, Arora, Bhavya, Dutta, Koel, Ghosh, Amerta, Sinha, Binayak, Misra, Anoop
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Diabetes India. Published by Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303633/ https://www.ncbi.nlm.nih.gov/pubmed/32604013 http://dx.doi.org/10.1016/j.dsx.2020.06.020

Ejemplares similares

Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India
por: Ghosh, Amerta, et al.
Publicado: (2020)

Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis
por: Ghosal, Samit, et al.
Publicado: (2020)

Roadblock in application of telemedicine for diabetes management in India during COVID19 pandemic
por: Ghosh, Amerta, et al.
Publicado: (2020)

Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians
por: Ghosh, Amerta, et al.
Publicado: (2020)

Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases
por: Mishra, Abha, et al.
Publicado: (2021)

Finerenone in type 2 diabetes and renal outcomes: A random-effects model meta-analysis
por: Ghosal, Samit, et al.
Publicado: (2023)

Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials
por: Sinha, Binayak, et al.
Publicado: (2020)

Assessing the Effects of Modern Renoprotective Agents in Preventing Progression of Renal Composite Outcomes in Patients with Type 2 Diabetes: A Network Meta-analysis
por: Ghosal, Samit, et al.
Publicado: (2022)

Exploring the comparative cardiovascular death benefits of sodium–glucose cotransporter 2 inhibitors in type 2 diabetes: a frequentist and Bayesian network meta-analysis-based scoring
por: Ghosal, Samit, et al.
Publicado: (2023)

Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India
por: Tyagi, Kanika, et al.
Publicado: (2021)

A Target HbA1c Between 7 and 7.7% Reduces Microvascular and Macrovascular Events in T2D Regardless of Duration of Diabetes: a Meta-Analysis of Randomized Controlled Trials
por: Sinha, Binayak, et al.
Publicado: (2021)

Meta‐analysis of the effects of sodium glucose cotransporter 2 inhibitors in non‐alcoholic fatty liver disease patients with type 2 diabetes
por: Sinha, Binayak, et al.
Publicado: (2020)

A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)
por: Ghosal, Samit, et al.
Publicado: (2021)

Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from India
por: Sinha, Binayak, et al.
Publicado: (2014)

Quantitative measure of asymptomatic cardiovascular disease risk in Type 2 diabetes: Evidence from Indian outpatient setting
por: Ghosal, Samit, et al.
Publicado: (2020)

Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOS
por: Ghosal, Samit, et al.
Publicado: (2016)

Sodium-Glucose Cotransporter-2 Inhibitors (SGLT-2i) Reduce Hospitalization for Heart Failure Only and Have No Effect on Atherosclerotic Cardiovascular Events: A Meta-Analysis
por: Sinha, Binayak, et al.
Publicado: (2019)

Rapid sputum testing and not thermal screening alone should be the first-line screening test at airports: A Bayesian analysis
por: Ghosal, Samit, et al.
Publicado: (2020)

A Meta-Analysis of the Effect of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic Parameters in Patients With Polycystic Ovary Syndrome
por: Sinha, Binayak, et al.
Publicado: (2022)

Efficacy of Digitally Supported and Real-Time Self-Monitoring of Blood Glucose-Driven Counseling in Patients with Type 2 Diabetes Mellitus: A Real-World, Retrospective Study in North India
por: Sabharwal, Mudit, et al.
Publicado: (2022)

COVID19 induced acute pancreatitis and pancreatic necrosis in a patient with type 2 diabetes
por: Ghosh, Amerta, et al.
Publicado: (2020)

Marked hyperglycemia and ketosis in a non-obese patient with new onset diabetes and very mild COVID-19 symptoms: A case report
por: Ghosh, Amerta, et al.
Publicado: (2021)

Linear Regression Analysis to predict the number of deaths in India due to SARS-CoV-2 at 6 weeks from day 0 (100 cases - March 14th 2020)
por: Ghosal, Samit, et al.
Publicado: (2020)

Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification
por: Misra, Anoop, et al.
Publicado: (2021)

LBODP046 Reduction In "Cardiovascular Death Or Hospitalisation For Heart Failure" With Sglt-2is Is Dependent On Weight Reduction: A Meta-regression Analysis
por: Ghosal, Samit, et al.
Publicado: (2022)

Heterogeneity in cardiovascular death or hospitalization for heart failure benefits with flozins is linked to weight
por: Ghosal, Samit, et al.
Publicado: (2023)

“Compliance of the Indian National Task Force guidelines for COVID-19 recommendation by Indian doctors – A survey"
por: Gangopadhyay, Kalyan Kumar, et al.
Publicado: (2020)

Clinical considerations for patients with diabetes in times of COVID-19 epidemic
por: Gupta, Ritesh, et al.
Publicado: (2020)

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: A case-control study
por: Mittal, Juhi, et al.
Publicado: (2021)

Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study
por: Ghosh, Amerta, et al.
Publicado: (2021)

Reply to letter to the editor regarding article: Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis (Ghosal et al.)
por: Ghosal, Samit
Publicado: (2020)

Impact of COVID-19 pandemic and lockdown in a cohort of myasthenia gravis patients in India
por: Kalita, Jayantee, et al.
Publicado: (2021)

Impact of complete lockdown on total infection and death rates: A hierarchical cluster analysis
por: Ghosal, Samit, et al.
Publicado: (2020)

Sugar Intake, Obesity, and Diabetes in India
por: Gulati, Seema, et al.
Publicado: (2014)

Management of diabetes mellitus through teleconsultation during COVID-19 and similar scenarios - Guidelines from Indian Council of Medical Research (ICMR) expert group
por: Sarveswaran, Gokul, et al.
Publicado: (2021)

Infections and diabetes: Risks and mitigation with reference to India
por: Unnikrishnan, Ranjit, et al.
Publicado: (2020)

Resurgence of COVID-19 and diabetes in India
por: Pal, Rimesh, et al.
Publicado: (2021)

Majorly Resurgent and Uncontrolled Diabetes During COVID19 Era, and in the Future Can Be Contained in India
por: Misra, Anoop
Publicado: (2021)

COVID-19 pandemic and challenges for socio-economic issues, healthcare and National Health Programs in India
por: Gopalan, Hema S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_50mhtubom78rrbbakhak6cnk6b